Ignacio Cruz‐González
A5069507925- Cardiac Valve Diseases and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Cardiac Structural Anomalies and Repair
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Cardiac tumors and thrombi
- Aortic Disease and Treatment Approaches
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac, Anesthesia and Surgical Outcomes
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular and Diving-Related Complications
- Heart Failure Treatment and Management
- COVID-19 and healthcare impacts
- Cardiovascular Syncope and Autonomic Disorders
- Cardiac electrophysiology and arrhythmias
- Mechanical Circulatory Support Devices
- Health Systems, Economic Evaluations, Quality of Life
- Vascular Procedures and Complications
- Congenital Heart Disease Studies
- Heparin-Induced Thrombocytopenia and Thrombosis
Complejo Hospitalario de Salamanca
2016-2025
Centro de Investigación en Red en Enfermedades Cardiovasculares
2017-2025
Instituto de Investigación Biomédica de Salamanca
2016-2025
Universidad de Salamanca
2016-2025
Centro de Investigación Biomédica en Red
2018-2025
St. Eugenio Hospital
2024
ASL Roma
2024
Centre Cardiologique du Nord
2024
University Hospital of Basel
2024
Hospital Clínico San Carlos
2021-2024
To investigate the safety, feasibility, and efficacy of left atrial appendage occlusion (LAAO) with AMPLATZER Cardiac Plug (ACP) for stroke prevention in patients fibrillation (AF).Data from consecutive treated 22 centres were collected. A total 1,047 included study. Procedural success was 97.3%. There 52 (4.97%) periprocedural major adverse events. Follow-up complete 1,001/1,019 (98.2%) successfully implanted (average 13 months, 1,349 patient-years). One-year all-cause mortality 4.2%. No...
To investigate if recent technical and procedural developments in percutaneous coronary intervention (PCI) significantly influence outcomes appropriately selected patients with three-vessel (3VD) artery disease.The SYNTAX II study is a multicenter, all-comers, open-label, single arm that investigated the impact of contemporary PCI strategy on clinical 3VD 22 centres from four European countries. The SYNTAX-II includes: heart team decision-making utilizing Score (a tool combining anatomical...
Background: Left atrial appendage occlusion with WATCHMAN has emerged as viable alternative to vitamin K antagonists in randomized controlled trials. Evaluating real-life clinical outcomes fibrillation patients receiving the left closure technology was designed collect prospective multicenter of thromboembolic events, bleeding, and mortality for implanted a routine daily practice. Methods: One thousand twenty implant procedure were prospectively followed 47 centers. indication based on...
The global, prospective AMPLATZER Amulet observational study documents real-world periprocedural, transoesophageal echocardiographic (TEE) and clinical outcomes from left atrial appendage occlusion (LAAO) using the device. aim of this report is to describe periprocedural early clinical/TEE results study.This multicentre registry included 1,088 patients (75±8.5 years, 64.5% male, CHA2DS2-VASc: 4.2±1.6, HAS-BLED: 3.3±1.1) with non-valvular fibrillation; 82.8% were considered have an absolute...
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of heart-failure admission among high-risk patients. However, most patients with valvular heart disease, including those undergoing transcatheter aortic-valve implantation (TAVI), have been excluded from randomized trials. We conducted this randomized, controlled trial in Spain to evaluate efficacy dapagliflozin (at a dose 10 mg once daily) as compared standard care alone aortic stenosis who were TAVI. All had history failure...
Introducción y objetivos: La epidemia de COVID-19 la declaración del estado alarma han propiciado una disminución en actividad cardiología intervencionista.El objetivo este estudio es cuantificar esta disminución, con especial interés el funcionamiento código infarto.Métodos: Se realizó encuesta telemática a 81 centros las 17 comunidades autónomas españolas procedimientos infarto.Se recogió información sobre diagnóstica, intervencionismo coronario, estructural seno infarto agudo miocardio...
This document aims to describe a standardised methodology for performing left atrial appendage occlusion (LAAO) using the AMPLATZER Amulet device, and provide useful tips tricks operators with different levels of experience.Physicians who are experts in LAAO had personal clinical experience device were asked contribute preparation this consensus document. Twenty-seven physicians (20 interventional cardiologists 7 electrophysiologists) from 14 countries reviewed manuscript. A step-by-step...
The aim of this study was to assess clinical and prognosis differences in patients with COVID-19 STEMI.Using a nationwide registry consecutive managed within 42 specific STEMI care networks, we compared patient procedure characteristics in-hospital outcomes two different cohorts, according whether or not they had COVID-19. Among 1,010 patients, 91 were identified as having (9.0%). With the exception smoking status (more frequent non-COVID-19 patients) previous coronary artery disease...
Background: Left atrial appendage closure is an established therapy in patients with fibrillation. Although device-related thrombosis (DRT) relatively rare, it potentially linked to adverse events. As data on DRT characteristics, outcome, and treatment regimen are scarce, we aimed assess these questions a multicenter approach. Methods: One hundred fifty-six the diagnosis of after left were included multinational EUROC-DRT registry. Baseline characteristics clinical echocardiographic data....
Abstract Aims The SYNTAX II study evaluated the impact of advances in percutaneous coronary intervention (PCI), integrated into a single revascularization strategy, on outcomes patients with de novo three-vessel disease. employed decision-making utilizing score II, use physiology, thin-strut biodegradable polymer drug-eluting stents, intravascular ultrasound, enhanced treatments chronic total occlusions, and optimized medical therapy. Patients treated this approach were compared predefined...
Data on procedural and early outcomes after transjugular transcatheter tricuspid valve replacement (TTVR) are limited.
The high prevalence of type 2 diabetes and atherosclerosis makes essential the availability in vivo experimental models that accurately replicate pathophysiological mechanisms these diseases. Apolipoprotein E knockout mice (ApoE
Current echocardiographic scoring systems for percutaneous mitral valvuloplasty (PMV) have limitations. This study examined new, more quantitative methods assessing valvular involvement and the combination of parameters that best predicts immediate long-term outcome after PMV.Two cohorts (derivation n=204 validation n=121) patients with symptomatic stenosis undergoing PMV were studied. Mitral valve morphology was assessed by using both conventional Wilkins qualitative novel parameters,...